Section 3: The Top 200 Prescriptions Drug Part III Endocrine Metabolic Agents

$140.00

AGD Member:  98.00*

Student Member: 75.00*

Speaker:  Geza T. Terezhalmy, DDS, MA

Non-Member: 140.00

Credit Hours 3.25

Subject Code: 340 – Anesthesia and Pain Management

*AGD Member discount applied at checkout.

Category:

Description

Course Abstract:

Our primary obligation and ultimate reasonability is the timely delivery of quality diagnostic, preventive, and therapeutic services, within the bounds of the clinical circumstances presented by patients. Consequently, we must possess knowledge and skills essential to determine the functional state of patients to undergo and respond to dental care. Diagnostic activities should be validated and focused not only on identifying those problems that one cannot afford to miss but also to identify those patients with an increased likelihood of developing a disease and those who may experience an increase in disease severity or a medical emergency in the perioperative period.

Course Description:

Introduce evidence-based knowledge essential for risk stratification and dental management of patients with endocrine disorders.

Learning Objectives:

  1. Discuss the medical management of patients with endocrine disorders predicated on the top 200 prescription drugs
  2. Discuss disease-related, treatment-related, and procedure-related variables
  3. Develop therapeutic strategies predicated on the patient’s ability to undergo and respond to dental care

 

Dr. Geza T. Terezhalmy received his D.D.S. degree from Case Western Reserve School of Dental Medicine and his M.A. from The George Washington University. Currently he is a professor for the Department of Comprehensive Dentistry at the University of Texas Health Science Center at the San Antonio Dental School. He is also a clinical professor for the Department of Pharmacology at the Graduate School of Biomedical Sciences at the University of Texas Health Science Center at the San Antonio Dental School. Dr. Terezhalmy serves as a National Consultant for Dental Pharmacotherapeutics to the US Surgeon General and also to the Naval Postgraduate Dental School as a consultant in their department of Oral Medicine. He has served on the editorial boards of Quintessence International, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology and has an extensive list of publication credits with articles appearing in The American Journal of Dentistry, The International Journal of Dental Hygiene, the Journal of Contemporary Dental Practice and the Archives of Oral Biology. Dr. Terezhalmy has served as president of the Organization of Teachers of Oral Diagnosis and of the American Academy of Oral Medicine.

Additional information

Expiration Date

October 23, 2021

Reviews

There are no reviews yet.

Be the first to review “Section 3: The Top 200 Prescriptions Drug Part III Endocrine Metabolic Agents”
<